A 50-55 kDa soluble form of IL-6R (sIL-6R) lacking the transmembrane and cytoplasmic portion 7 has been purified from human urine. 8 It is released from normal human The relationship between interleukin-6 (IL-6) and the soluble interleukin-6 receptor (sIL-6R) was analyzed in PBMC after PHA stimulation, from U937 promonocytic cells and from human T cell leukemia virus-I (HTLV-I)-1481 serum samples of 82 patients after bone marrow or peripheral blood cell transplantation. The cytokine positive cell lines, and is also detected in normal serum.
Patients
During bone marrow transplantation distinct alterations in the network of cytokines can be observed. These occur in From 1991 to 1994, 82 consecutive patients undergoing the context of inflammatory processes due to infections or allogeneic (n = 38), autologous (n = 7) or syngeneic (n = graft-versus-host disease. IL-6 has been found to be elev-1) bone marrow transplantation, or peripheral blood stem ated during transplant-related complications. [1] [2] [3] Recently, cell transplantation (PBSCT, n = 36) were included in this we have described elevated serum levels during the aplastic analysis. The patients suffered from chronic myeloid leukephase after allogeneic and autologous bone marrow transmia (CML, n = 13), non-Hodgkin's lymphoma (NHL, n = plantation or after peripheral blood stem cell transplan-18), relapsed Hodgkin's disease (HD, n = 6), acute myeloid tation; it could be shown that IL-6 serum levels correlated leukemia (AML, n = 16), acute lymphoid leukemia (ALL, with fever and C-reactive protein. 4 n = 9), breast cancer with axillary lymph node involvement IL-6 is a multifunctional cytokine which is produced by (n = 12), aplastic anemia (n = 2), multiple myeloma (n = a variety of cell types. 5 By interaction with a specific mem-3), germ cell tumor (n = l) and myelodysplastic syndrome brane receptor it can exert its biological effects upon B (MDS, n = 2). cells, T cells, macrophages, hepatocytes, myeloma cells and neuronal cells. 6 The human membrane receptor has been Procedure of bone marrow transplantation characterized to be composed of two chains: a ligand-binding glycoprotein gp80 (referred to as IL-6 receptor (IL-6R))
Patients with CML, AML, NHL, and multiple myeloma and a signal transducing glycoprotein gp130. 6 Binding of received busulfan (BU, 16 mg/kg), VP-16 (30-45 mg/kg), IL-6 to the gp80 triggers the association of this complex to and cyclophosphamide (CY, 120 mg/kg). Patients with aplthe non-ligand-binding gp130.
astic anemia received CY (200 mg/kg), and antithymocyte globulin (ATG, 100 mg/kg). Patients with HD were conditioned using 150 mg/kg CY, 300 mg/m 2 BCNU, and 1 mg/m 2 ), MDS patients received 16 mg/kg BU and 120 detection was 2 pg/ml IL-6. The coefficient of variation within the assay is about 5%. mg/kg CY. Patients with ALL and T cell NHL underwent total body irradiation (12 Gy), VP-16 (45 mg/kg), and CY (100 mg/kg).
Detection of sIL-6R Allogeneic transplantation 14 was performed using a non-T cell-depleted marrow from HLA-matched sibling donors.
The quantification of sIL-6R was performed by a solid phase sandwich enzyme-linked immuno sorbent assay GVHD prophylaxis consisted of low-dose methotrexate (5 mg/m 2 at day 1, 4, 7 and 11) and cyclosporin A from day (ELISA; BioSource, Camarillo, CA, USA). This ELISA detects sIL-6R as single molecule or bound to IL-6 and −1 (3 mg/kg i.v.).
Prior to admittance, all patients were carefully examined does not interfere with IL-6. In the assay, a microtiter plate is coated with antibodies specific for sIL6R (capture to rule out an infectious focus, including X-rays of lung, teeth, paranasal cavities and mastoids. Ciprofloxacin, fluantibodies). Serum probes or standards of known sIL-6R content are applied to the wells, and a biotinylated second conazole, and cotrimoxazole were given prophylactically throughout the procedure. Acyclovir was started on day 1. monoclonal antibody directed against another epitope of IL-6R is added. After incubation and washing, streptavidinAntibiotic combination therapy was administered for fever and amphotericin B was added for documented fungal peroxidase-conjugate is added followed by a second incubation and washing. Finally, TMB-substrate solution is infection or persistent fever. Routine microbiological swabs of mouth, nose, ears, perianal region, vagina or penis were added, and after incubation, the absorbance of the microtiter plate is read at 450 nm. The minimum detectable done twice weekly. When temperature exceeded 38°C, blood cultures were drawn, and stool, urine, sputum, and concentration of sIL-6R is 5 pg/ml. The coefficient of variation within the assay is 4-7%. throat swabs were examined. A platelet count above 20 × 10 9 was maintained by HLA-A/B-similar CMVseronegative single donor platelet transfusions, and packed
Statistical analysis red cells were given when the hemoglobin was Ͻ8.0 g/dl. Seventy-five patients received 10-30 g/kg/day G-CSF For the univariate description of the IL-6 and sIL-6R values over time, box whisker plots were shown representing the (Neupogen; Hoffmann-La Roche, Grenzach-Wyhlen, Germany) by continous infusion starting from day +l (n = daily median and the first and third quartiles, as well as the extremes. 69), day +5 (n = 1) or day + 10 (n = 5).
To analyze the strength of the relationship between IL-6 and sIL-6R, Spearman rank correlation coefficients (r s ) Sample collection were calculated separately for each patient using data starting at day 0. These measures are especially useful to detect Blood samples were collected each morning with the monotonic relationships between two variables with the exception of Saturdays and Sundays from day −3 before advantage of being robust against potentially outlying until day +21 after transplantation. All samples were observations. The distribution of these coefficients was allowed to clot. Serum was removed and stored in aliquots described. Additionally, the associated empirical distriat −80°C until assayed.
bution function is presented. This function evaluated at a specific value r s , gives the cumulative relative frequency of patients with a Spearman rank correlation coefficient of IL-6 assay equal or less than r s . Sign test was performed to investigate whether the correlation coefficients differ significantly from The amount of IL-6 in the serum was measured with a standardized enzyme amplified sensitivity immunoassay 0. Furthermore, each individual correlation coefficient was weighted by the number of samples collected per individual (EASIA; Medgenix, Brussels, Belgium) which was based on an oligoclonal system with several monoclonal antito yield the average intra-individual Spearman rank correlation coefficient (weighted intra-individual r s ) as a bodies directed against distinct epitopes of IL-6. This EASIA detects all IL-6 molecules (free IL-6, IL-6 bound summary measure. to soluble IL-6 receptors, biologically inactive IL-6). The assay was performed according to the manufacturer's instructions and calibrated with cytokine standards comResults mercially added to the kits. Briefly, monoclonal anti IL-6 'capture antibodies' were attached to the surface of plastic
The serum levels of IL-6 and sIL-6R were measured in 1481 serum samples from 82 consecutive patients undergowells of a microtiter plate. Standards or serum samples were added to the well. After incubation and washing, ing allogeneic, autologous or syngeneic bone marrow transplantation or peripheral blood stem cell transplantation. A monoclonal horseradish-labeled IL-6 antibodies were added. After incubation and washing, the revelation solmedian of 18 measurements per patient (range 8 to 33) was used for statistical analysis ( Table 1) . The cytokine and its ution (tetramethylbenzydine, H 2 0 2 ) was added and incubated. The reaction was stopped, and the absorbance of the receptor were measured on a daily basis starting at day −3 before transplantation and ending at day +21 after transmicrotiter plate was read at 450 nm. The absorbance is proportional to the IL-6 concentration. Standard curves were plantation ( Figure 1 ). The average IL-6 serum levels of all patients increased in the course post transplantation, culmiplotted, and cytokine concentrations in the samples were determined by interpolation from these curves. The limit of nated at day 6 with a median of 130 pg/ml and then 717 Table 1 Spearman rank correlation between IL-6 and sIL-6R serum A statistical analysis of the relationship between IL-6 and levels sIL-6R was performed by calculation of the individual Spearman rank correlation coefficients. The weighted intra-individual Spearman rank correlation The IL-6 receptor system has been identified as consisting of two polypeptide chains, ie a ligand-specific receptor (IL-6R) and a signal transducer (gp130). 6 This unique receptor system could explain functional pleiotropy and redundancy of cytokines. Obviously, gp130 is ubiquitously expressed in all organs examined; 15 even cells that do not express IL-6R can express gp130 suggesting that gp130 functions as a signal transducer for various other cytokines or cytokine receptors. Thus, a number of hematopoietic, cardiotrophic and neurotrophic cytokines, other than IL-6, use gp130 as a component of their receptor system, including LIF (leukemia inhibitory factor), OM (oncostatin-M), IL-11 (interleukin-11), CT-1 (cardiotrophin-1), and CNTF (ciliary neurotrophic factor). 6 As expected from the pleiotropic functions of IL-6, IL-6R is expressed in various tissues and cells 16 Day sIL-6 Receptor (ng/ml) Figure 1 Time course of the mean IL-6 and sIL-6R serum concentrations from day −3 up to day +21 after bone marrow or peripheral blood stem cell transplantation. Minimum, maximum, first and third quartiles and median are graphically represented by box plots.
returned toward baseline values. In contrast, levels of sIL-6R which were analyzed in the identical blood samples decreased after transplantation to a minimal median of about 70 ng/ml at day 6 and then increased again up to day 21. There was no difference found comparing IL-6 and sIL- in patients receiving G-CSF or not.
alternative spliced RNA. 25,26 Soluble IL-6R lacks the trans-IL-6 were performed by an ELISA detecting all IL-6 molmembrane and intracytoplasmic domains. 7 It has been ecules whether free or bound to sIL-6R. The ELISA for expressed successfully and shown to be able to associate the detection of sIL-6R molecules was not influenced by with gp130 in the presence of IL-6 and to mediate the functhe presence of IL-6. The time course described here of sILtion of its membrane form. 7, 27 In this context, it should be 6R serum levels is in accordance with data on four patients noted also that the gp130 can be released from the cell as published by others. 11 These authors performed longitudia 100 kDa soluble protein; the extend of shedding of gp130, nal measurements of serum sIL-6R over a period of 2 years however, is almost negligible when compared with and showed a 50% decrease followed by a rapid increase of shedding of the IL-6R. 28 these levels during the hematopoietic recovery phase after The biological function and clinical significance of sILallogeneic bone marrow transplantation. However, they did 6R is largely unknown. It can be suggested that sIL-6R not compare sIL-6R with IL-6. In another study, sIL-6R plays a role in the regulation of the IL-6 response. Thus, and IL-6 serum levels were evaluated in 24 patients followafter forming a complex IL-6/sIL-6R, the binding may proing allogeneic or autologous bone marrow transplantation.
37 tect IL-6 from protease degradation similar to that reported Soluble IL-6R levels were described to correlate positively for IL-4 and its soluble receptor 29 and/or may stabilize ILwith engraftment, and both sIL-6R and IL-6 levels were 6 structure and preserve its bioactivity as shown for TNF found to be significantly elevated in patients who developed and its soluble receptors. 30 Circulating IL-6/sIL-6R comacute graft-versus-host disease or early relapse following plexes are found in the serum of patients with systemic bone marrow transplantation. However, since these authors juvenile rheumatoid arthritis 13 and patients with advanced analyzed IL-6 and its soluble receptor at only three points solid tumors subjected to rhIL-6. 31 Furthermore, the comafter relatively long time intervals (day −10, day 0, day of plex might associate with gp130 on the cell surface and engraftment), an exact comparison of both parameters over thus render cells, which by themselves cannot bind IL-6, a period of time, as performed in the present investigation, IL-6 responsive or augment the sensitivity of cells to is not possible. IL-6.
An inverse correlation between IL-6 and sIL-6R has been Evidence for an increased IL-6-response by sIL-6R are reported in cord blood of 13 septic newborns. 38 In another that sIL-6R enhanced the growth-inhibitory effect of IL-6 study, the relation of IL-6 and sIL-6R was evaluated in 29 on breast carcinoma cells 32 and augmented the IL-6-serum samples of patients with systemic juvenile rheumainduced production of ␣ 1 -antitrypsin and haptoglobin in toid arthritis. 13 The data showed a negative correlation (r HepG2 hepatoma cells both on the mRNA and protein = −0.618) between serum IL-6 levels with serum sIL-6R level. 33 Other examples are plasma cell dyscrasias. Since levels, and furthermore in two patients an increase in serum physiological concentrations of sIL-6R can potentiate IL-IL-6 levels during a febrile peak was associated with a 6-dependent proliferation of human myeloma cell lines, 11 decrease in serum sIL-6R levels. The authors suggested that it can be speculated that sIL-6R may act on plasma cells two possible mechanisms may account for the decrease in as an agonist. Some authors described increased serum levthe serum sIL-6R levels in patients with systemic juvenile els of sIL-6R in patients with plasma cell dyscrasias 11, 34 rheumatoid arthritis which may also hold true for patients and a correlation between sIL-6R serum level and disease after bone marrow transplantation. (1) A direct inhibitory activity, 34 while others did not find significant differences effect of increased in vivo IL-6 production on the in the sIL-6R levels between patient groups and controls. 35 There was no significant correlation between serum levels expression of the IL-6R gene. This is conceivable since of sIL-6R and other prognostic factors such as C-reactive direct effects of IL-6 on the IL-6R gene expression have protein or ␤2-microglobulin, and it can be concluded that been described. A down-regulation of IL-6R gene sIL-6R levels are not of significant prognostic value. 11, 34, 35 expression under the influence of IL-6 has been found for Furthermore, sIL-6R serum levels are not influenced by the monocytes, while IL-6R in cultured human primary hepatotumor cell mass; four patients with a high cell mass myelcytes is stimulated by 19 In contrast, a dramatic upoma and sIL-6R levels between 135-235 ng/ml did not regulation of IL-6R gene expression has been reported in have major changes in their longitudinally measured sILvitro and in vivo in IL-6-deprived myeloma cells suggesting 6R levels during the course of disease, independent of that IL-6 continuously represses the IL-6 gene expression whether these patients achieved complete remission or in myeloma cells in vivo. 39 Whether IL-6 also regulates the relapsed after bone marrow transplantation. 11 In contrast, it production of sIL-6R remains to be shown. (2) A second was reported that patients with raised levels of both sILpossible mechanism for the decrease of the serum sIL-6R 6R and ␤2-microglobulin had shorter survival than other level is a consumption of circulating sIL-6R due to formapatient groups indicating its prognostic value for the tion of IL-6/sIL-6R complexes in the presence of IL-6 and stratification of patients. 36 subsequent binding and internalization of the complexes by In the present work, we show an increase of serum ILtarget cells expressing the gp130 signal transducing protein. 6 during the aplastic phase after bone marrow or peripheral Circulating IL-6/sIL-6R complexes are found in patient blood stem cell transplantation culminating at day 6 folsera, 13, 31 and it has been reported that IL-6 can down-regulowed by a decrease to baseline values. The elevated IL-6 late the specific IL-6R after binding to IL-6 in vitro via values correlated with CRP and fever, and the day of peak internalization. 40 Down-regulation of IL-6R and consump-IL-6 value correlated with the day of platelet engraftment. 4 tion of IL-6/sIL-6 complexes could play a role in the proHere, we have found that IL-6 serum levels were negatively tection of cells against overstimulation. correlated with serum levels of sIL-6R. Measurements of vitro uptake of IL-6 in liver and hepatocytes. Eur J Clin Invest
